Edition:
United States

Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

2.06CAD
3:56pm EDT
Change (% chg)

$-0.14 (-6.36%)
Prev Close
$2.20
Open
$2.28
Day's High
$2.28
Day's Low
$2.06
Volume
1,640
Avg. Vol
7,630
52-wk High
$2.85
52-wk Low
$1.45

COV.V

Chart for COV.V

About

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating... (more)
No analyst recommendations are available for COV.V.

Overall

Beta: 1.53
Market Cap(Mil.): $46.95
Shares Outstanding(Mil.): 21.34
Dividend: --
Yield (%): --

Financials

  COV.V Industry Sector
P/E (TTM): -- 120.44 32.84
EPS (TTM): -0.10 -- --
ROI: -25.40 9.39 14.86
ROE: -27.50 14.54 16.11

BRIEF-Affiliate of Goldfarb Corporation acquires additional shares and warrants of Covalon

* Affiliate of Goldfarb Corporation acquires additional shares and warrants of Covalon

Jun 01 2017

BRIEF-Covalon Q2 earnings per share C$0.02

* Q2 earnings per share C$0.02 Source text for Eikon: Further company coverage:

May 29 2017

BRIEF-Covalon engages advisors to pursue strategic acquisitions

* Covalon engages advisors to pursue strategic acquisitions Source text for Eikon: Further company coverage:

May 16 2017

BRIEF-Covalon announces $2.6 million private placement and warrant exercise

* Covalon announces $2.6 million private placement and warrant exercise

May 12 2017

Earnings vs. Estimates

No consensus analysis data available.